CAR T

News
CellectisBest

Cellectis CAR-T trials on hold after patient death

Cellectis’  'off the shelf' CAR-T cancer therapy has hit a major setback after the first patient treated in a phase 1 study died, and the first patient treated in another developed life-thr

Views & Analysis
iStock 5380328781

Innovations in cancer drug research

While cancer continues to be one of the leading causes of death and illness, new technology and increasing use of real-world data have the potential to revolutionise care.